跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 104,257 条关于
“JAK 1/2”
全部
104,257
临床试验
68,754
药物
12,462
机构
2,471
资讯
20,570
去年
Sun Pharma Acquires Concert Pharmaceuticals to Advance Alopecia Areata Treatment
去年
Court Blocks Sun Pharma's Alopecia Drug Launch Following Incyte Patent Dispute
去年
Topical JAK/TYK Inhibitor TDM-180935 Shows Promise in Phase 2a Trial for Atopic Dermatitis
去年
Deuruxolitinib Demonstrates Efficacy in Hair Regrowth and Improves Patient Well-being in Severe Alopecia Areata
去年
New Phase 1 Trial Combines Tagraxofusp and Pacritinib for Treatment-Resistant Myelofibrosis
4年前
AbbVie's Risankizumab and Upadacitinib Show Promise in Phase 3 IBD Trials Published in The Lancet
7个月前
AbbVie Submits Upadacitinib for Vitiligo Treatment, Potentially First Systemic Therapy for Autoimmune Skin Disease
去年
Mankind Pharma Receives CDSCO Approval for Phase 1 Trial of JAK Inhibitor MKP11093 for Autoimmune Disorders
去年
JAK Inhibitors Show Promise in Treating Alopecia Areata
3个月前
Higher BMI Reduces Effectiveness of JAK Inhibitors in Rheumatoid Arthritis
第 1 页,共 2057 页
上一页
下一页